Atazanavir atazanavir is a structural analog of the transition state during which the bond between a phenylalanine and proline is broken. Humans do not have any enzymes that break bonds between phenylalanine and proline, so this drug will not target human enzymes. Atazanavir is available as a 150 mg capsule, 200 mg capsule, 300 mg capsule, and 50 mg oral powder packet. The 300 mg capsule should reduce pill burden, as one 300 mg capsule may replace two 150 mg capsules. Atazanavir Atazanavir, sold under the trade name Reyataz among others, is an antiretroviral medication used to treat and prevent HIV/AIDS.
State Institute for Drug Control on 195 reference groups of therapeutically interchangeable products of similar clinical efficacy. More than 20% of the health budget is spent on medication and medical devices. It allocates codes and names of medications for use in the electronic prescribing system. It has been criticised by KOPAC, the Patient Association for Cannabis Treatment, for failing to ensure a supply of Czech medical cannabis so that patients have to pay inflated prices for imported supplies. State Institute for Drug Control The State Institute for Drug Control (Státní ústav pro kontrolu léčiv), based in Prague is an institution of the government of the